Clik here to view.
AnHeart Therapeutics Announces Formation of Scientific Advisory Board
NEW YORK & HANGZHOU, China AnHeart Therapeutics (“AnHeart”), a clinical-stage global biopharmaceutical company committed to developing novel cancer therapies, announced today the formation of...
View ArticleClik here to view.
Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer...
TORONTO & SHANGHAI Cyclica, the partner of choice for data-driven drug discovery, and IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted...
View ArticleClik here to view.
Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of...
SAN DIEGO Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease...
View ArticleClik here to view.
AbCellera and Everest Medicines Announce Multi-Target Collaboration to...
VANCOUVER, British Columbia & SHANGHAI AbCellera (Nasdaq: ABCL) and Everest Medicines Limited (HKEX 1952.HK, “Everest”) announced today that they have entered into a multi-year collaboration and...
View ArticleClik here to view.
Astex Pharmaceuticals Presents Overall Survival Data From ASCERTAIN Phase 3...
PLEASANTON, Calif. Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan, today announced updated clinical data, including median overall...
View ArticleClik here to view.
Rhizen PharmaceuticalsがCovid-19患者でRP7214を検討する第2相試験で最初の患者への投与を発表
スイス・バーゼル （ビジネスワイヤ） — オンコロジー・炎症分野に傾注する臨床段階のバイオ製薬企業であるRhizen Pharmaceuticals...
View ArticleClik here to view.
NTHU Researchers Develop Ultrasonic Vortex Thrombolytic Device
HSINCHU, Taiwan As COVID-19 vaccination has raised the issue of thrombosis, Dr. Chih-Kuang Yeh, Distinguished Professor of the Department of Biomedical Engineering and Environmental Sciences, has...
View ArticleClik here to view.
Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药
瑞士巴塞尔 (美国商业资讯)–专注于肿瘤和炎症的临床阶段生物制药公司Rhizen Pharmaceuticals...
View ArticleClik here to view.
Saladax Biomedical宣布Salvatore J. Salamone博士荣获著名的C.E. Pippenger博士奖
宾夕法尼亚州伯利恒 (美国商业资讯)–Salvatore J. Salamone博士在意大利罗马召开的国际治疗药物监测和临床毒理学会(IATDMCT) 2021年年会上荣获享有盛誉的C.E....
View ArticleClik here to view.
TAE Life Sciences Announces Installation of First Accelerator-based Neutron...
FOOTHILL RANCH, Calif. TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced the successful...
View ArticleClik here to view.
Japan’s MHLW Approves PADCEV® (enfortumab vedotin) for Advanced Urothelial...
TOKYO & BOTHELL, Wash. Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Seagen Inc. (Nasdaq:SGEN) today announced that Japan’s Ministry of Health, Labour...
View ArticleClik here to view.
サラダックス・バイオメディカル、サルバトーレ・J・サラモネ博士が権威ある C.E. Pippenger博士賞を受賞したと発表
米ペンシルベニア州ベスレヘム （ビジネスワイヤ） — サルバトーレ・J・サラモネ博士が、イタリアのローマで開催された2021年国際治療薬物モニタリングおよび臨床毒物学会（IATDMCT）年次大会で、権威ある C.E....
View ArticleClik here to view.
Bio-Thera Solutions Expands Partnership with Pharmapark in Russia and other...
GUANGZHOU, China & MOSCOW Bio-Thera Solutions, Ltd. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today...
View ArticleClik here to view.
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel...
NEW YORK & HONG KONG Treadwell Therapeutics today announced the acquisition of TCRyption Inc., a company focusing on novel approaches to TCR based T cell therapy and a TIO Bioventures portfolio...
View ArticleClik here to view.
Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the...
GAINESVILLE, Fla. Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through...
View ArticleClik here to view.
Aurion Biotech Announces Medical Advisory Board
SEATTLE & BOSTON & TOKYO Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced the...
View ArticleClik here to view.
FitPet Plans to Establish ‘Global Integrated Pet Lifestyle Platform’ Based on...
SEOUL, South Korea “We are creating a one-stop ecosystem for effective healthcare for pets.” The age has come when pets can be checked and managed with a simple diagnostic kit without having to go...
View ArticleClik here to view.
Treadwell Therapeutics宣布收购专注于新型TCR-T细胞疗法的TIO Bioventures投资组合公司TCRyption Inc.
纽约和香港 (美国商业资讯)–Treadwell Therapeutics今天宣布收购TCRyption Inc.，后者专注于新型TCR-T细胞疗法，是TIO...
View ArticleClik here to view.
BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib)...
CAMBRIDGE, Mass. & BEIJING & MOSCOW BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve...
View ArticleClik here to view.
硕迪B轮成功融资1亿美元，利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
旧金山和上海 (美国商业资讯)—硕迪生物技术有限公司（ShouTi Inc.）是一家临床阶段的生物制药公司，致力于利用先进计算和基于结构的技术开发改变患者命运的药物。该公司今日宣布已完成由BVF Partners L.P.（BVF）领投的1亿美元B轮融资。其他新晋投资方包括Casdin Capital、Cormorant Asset Management、Janus Henderson...
View Article